122 related articles for article (PubMed ID: 34862872)
1. Effects of dexmedetomidine on the degree of myocardial ischemia-reperfusion injury, oxidative stress and TLR4/NF-κB signaling pathway in rats.
Liu Y; Qu X; Zhang J; Wang X; Wang J
Pak J Pharm Sci; 2021 Sep; 34(5(Special)):2047-2051. PubMed ID: 34862872
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of ghrelin against oxidative stress, inducible nitric oxide synthase and inflammation in a mouse model of myocardial ischemia/reperfusion injury via the HMGB1 and TLR4/NF-κB pathway.
Sun N; Wang H; Wang L
Mol Med Rep; 2016 Sep; 14(3):2764-70. PubMed ID: 27485280
[TBL] [Abstract][Full Text] [Related]
4. Vaspin protects rats against myocardial ischemia/reperfusion injury (MIRI) through the TLR4/NF-κB signaling pathway.
Yuan L; Dai X; Fu H; Sui D; Lin L; Yang L; Zha P; Wang X; Gong G
Eur J Pharmacol; 2018 Sep; 835():132-139. PubMed ID: 30063916
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway.
Yang YF; Peng K; Liu H; Meng XW; Zhang JJ; Ji FH
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):353-361. PubMed ID: 27998004
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis.
Zhang X; Li Y; Wang Y; Zhuang Y; Ren X; Yang K; Ma W; Zhong M
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406910
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
[TBL] [Abstract][Full Text] [Related]
8. Arginase-2 protects myocardial ischemia-reperfusion injury via NF-κB/TNF-α pathway.
Huang XW; Pan MD; Du PH; Wang LX
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6529-6537. PubMed ID: 30338823
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN
Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of 4-methylumbelliferone on myocardial ischemia/reperfusion injury in rats through inhibition of oxidative stress and downregulation of TLR4/NF-κB/NLRP3 signaling pathway.
Moradi A; Aslani MR; Mirshekari Jahangiri H; Naderi N; Aboutaleb N
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5015-5027. PubMed ID: 38183448
[TBL] [Abstract][Full Text] [Related]
11. Betulin Alleviates Myocardial Ischemia-Reperfusion Injury in Rats via Regulating the Siti1/NLRP3/NF-κB Signaling Pathway.
Yu C; Cai X; Liu X; Liu J; Zhu N
Inflammation; 2021 Jun; 44(3):1096-1107. PubMed ID: 33392937
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway.
Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH
PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
Xue BB; Chen BH; Tang YN; Weng CW; Lin LN
Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
Li J; Zhao Y; Zhou N; Li L; Li K
J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
[TBL] [Abstract][Full Text] [Related]
15. Morphine alleviates myocardial ischemia/reperfusion injury in rats by inhibiting TLR4/NF-κB signaling pathway.
Wang Y; Wang L; Li JH; Zhao HW; Zhang FZ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8616-8624. PubMed ID: 31646595
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
[TBL] [Abstract][Full Text] [Related]
17. Role of Keap1-Nrf2/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia/reperfusion injury.
Li HX; Wang TH; Wu LX; Xue FS; Zhang GH; Yan T
Biosci Rep; 2022 Sep; 42(9):. PubMed ID: 35959640
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
19. Effect of miR-21/TLR4/NF-κB pathway on myocardial apoptosis in rats with myocardial ischemia-reperfusion.
Pan YQ; Li J; Li XW; Li YC; Li J; Lin JF
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7928-7937. PubMed ID: 30536340
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4/NF-κB pathways model of cerebral ischemia reperfusion.
Wang SL; Duan L; Xia B; Liu Z; Wang Y; Wang GM
Biomed Pharmacother; 2017 Sep; 93():1337-1342. PubMed ID: 28753906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
